CVE-2010-0959
Cross-site scripting (XSS) vulnerability in WebEditor/Authentication/LoginPage.aspx in IBM ENOVIA...
Cross-site scripting (XSS) vulnerability in WebEditor/Authentication/LoginPage.aspx in IBM ENOVIA SmarTeam 5 allows remote attackers to inject arbitrary web script or HTML via the errMsg parameter.
Exploit likelihood
What each source reports
NVD Score used
Cross-site scripting (XSS) vulnerability in WebEditor/Authentication/LoginPage.aspx in IBM ENOVIA SmarTeam 5 allows remote attackers to inject arbitrary web script or HTML via the errMsg parameter.
- Record
CVE-2010-0959- CVSS 2.0
- 4.3 Medium
AV:N/AC:M/Au:N/C:N/I:P/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
CVE List No score
Cross-site scripting (XSS) vulnerability in WebEditor/Authentication/LoginPage.aspx in IBM ENOVIA SmarTeam 5 allows remote attackers to inject arbitrary web script or HTML via the errMsg parameter.
- Record
CVE-2010-0959- Updated
- 2026-11-02
EUVDEUVD-2010-0984 No score
Cross-site scripting (XSS) vulnerability in WebEditor/Authentication/LoginPage.aspx in IBM ENOVIA SmarTeam 5 allows remote attackers to inject arbitrary web script or HTML via the errMsg parameter.
- Record
EUVD-2010-0984- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-hfp9-4vqx-x487 No score
Cross-site scripting (XSS) vulnerability in WebEditor/Authentication/LoginPage.aspx in IBM ENOVIA...
Cross-site scripting (XSS) vulnerability in WebEditor/Authentication/LoginPage.aspx in IBM ENOVIA SmarTeam 5 allows remote attackers to inject arbitrary web script or HTML via the errMsg parameter.
- Record
GHSA-hfp9-4vqx-x487- Weakness
- CWE-79
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2010-0959 is a medium vulnerability (CVSS 4.3) in Ibm Enovia Smarteam, published March 10, 2010. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.10%, the 65th percentile. No source names a fixed version.